# Intravenous Iron in paTients With Heart failURe and Reduced Ejection fracTion (HFREF) pLus Iron dEficiency

> **NCT03079518** · PHASE2 · COMPLETED · sponsor: **RWTH Aachen University** · enrollment: 23 (actual)

## Conditions studied

- Heart Failure, Systolic
- Iron Deficiency

## Interventions

- **DRUG:** Ferric Carboxymaltose
- **OTHER:** blood withdrawal

## Key facts

- **NCT ID:** NCT03079518
- **Lead sponsor:** RWTH Aachen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-10
- **Primary completion:** 2017-10-25
- **Final completion:** 2017-10-25
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2017-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03079518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03079518, "Intravenous Iron in paTients With Heart failURe and Reduced Ejection fracTion (HFREF) pLus Iron dEficiency". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03079518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*